RYTM logo

Rhythm Pharmaceuticals, Inc. (RYTM) EBIT

annual EBIT:

-$239.65M-$69.43M(-40.79%)
December 31, 2024

Summary

  • As of today (July 11, 2025), RYTM annual earnings before interest & taxes is -$239.65 million, with the most recent change of -$69.43 million (-40.79%) on December 31, 2024.
  • During the last 3 years, RYTM annual EBIT has fallen by -$170.04 million (-244.27%).
  • RYTM annual EBIT is now -2166.65% below its all-time high of -$10.57 million, reached on December 31, 2015.

Performance

RYTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

quarterly EBIT:

-$44.01M-$6.07M(-16.01%)
March 31, 2025

Summary

  • As of today (July 11, 2025), RYTM quarterly earnings before interest & taxes is -$44.01 million, with the most recent change of -$6.07 million (-16.01%) on March 31, 2025.
  • Over the past year, RYTM quarterly EBIT has increased by +$92.31 million (+67.72%).
  • RYTM quarterly EBIT is now -588.82% below its all-time high of -$6.39 million, reached on March 31, 2017.

Performance

RYTM quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

TTM EBIT:

-$147.87M+$92.31M(+38.43%)
March 31, 2025

Summary

  • As of today (July 11, 2025), RYTM TTM earnings before interest & taxes is -$147.87 million, with the most recent change of +$92.31 million (+38.43%) on March 31, 2025.
  • Over the past year, RYTM TTM EBIT has increased by +$109.38 million (+42.52%).
  • RYTM TTM EBIT is now -2210.05% below its all-time high of -$6.40 million, reached on September 30, 2016.

Performance

RYTM TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRYTMincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

RYTM EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-40.8%+67.7%+42.5%
3 y3 years-244.3%+16.6%+21.4%
5 y5 years-64.2%-24.7%-6.7%

RYTM EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-244.3%at low-61.9%+67.7%at high+42.5%
5 y5-year-244.3%at low-61.9%+67.7%-11.1%+42.5%
alltimeall time-2166.7%at low-588.8%+67.7%-2210.1%+42.5%

RYTM EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$44.01M(+16.0%)
-$147.87M(-38.4%)
Dec 2024
-$239.65M(+40.8%)
-$37.94M(-2.1%)
-$240.17M(+0.4%)
Sep 2024
-
-$38.74M(+42.5%)
-$239.13M(-0.8%)
Jun 2024
-
-$27.18M(-80.1%)
-$241.03M(-6.3%)
Mar 2024
-
-$136.32M(+269.6%)
-$257.25M(+51.3%)
Dec 2023
-$170.22M(-3.2%)
-$36.89M(-9.2%)
-$170.05M(-1.5%)
Sep 2023
-
-$40.65M(-6.3%)
-$172.65M(+1.1%)
Jun 2023
-
-$43.40M(-11.6%)
-$170.72M(-0.9%)
Mar 2023
-
-$49.12M(+24.4%)
-$172.27M(-2.1%)
Dec 2022
-$175.92M(+152.7%)
-$39.48M(+2.0%)
-$175.92M(-6.1%)
Sep 2022
-
-$38.72M(-13.9%)
-$187.29M(-2.8%)
Jun 2022
-
-$44.95M(-14.8%)
-$192.68M(+2.4%)
Mar 2022
-
-$52.76M(+3.8%)
-$188.15M(+10.8%)
Dec 2021
-$69.61M(-48.0%)
-$50.85M(+15.3%)
-$169.79M(+12.1%)
Sep 2021
-
-$44.10M(+9.1%)
-$151.43M(+6.9%)
Jun 2021
-
-$40.43M(+17.5%)
-$141.61M(+6.4%)
Mar 2021
-
-$34.40M(+5.9%)
-$133.09M(-0.7%)
Dec 2020
-$134.00M
-$32.49M(-5.2%)
-$134.00M(-1.3%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$34.28M(+7.4%)
-$135.73M(-2.0%)
Jun 2020
-
-$31.92M(-9.6%)
-$138.55M(-8.1%)
Mar 2020
-
-$35.30M(+3.1%)
-$150.78M(+3.3%)
Dec 2019
-$146.00M(+86.2%)
-$34.22M(-7.8%)
-$146.00M(+5.1%)
Sep 2019
-
-$37.11M(-16.0%)
-$138.93M(+14.8%)
Jun 2019
-
-$44.15M(+44.7%)
-$121.06M(+31.7%)
Mar 2019
-
-$30.52M(+12.4%)
-$91.94M(+17.2%)
Dec 2018
-$78.42M(+141.9%)
-$27.15M(+41.1%)
-$78.42M(+26.0%)
Sep 2018
-
-$19.24M(+28.1%)
-$62.25M(+21.4%)
Jun 2018
-
-$15.02M(-11.6%)
-$51.29M(+19.2%)
Mar 2018
-
-$17.00M(+54.8%)
-$43.02M(+32.7%)
Dec 2017
-$32.41M(+25.1%)
-$10.98M(+32.5%)
-$32.41M(+8.8%)
Sep 2017
-
-$8.29M(+22.7%)
-$29.80M(+6.8%)
Jun 2017
-
-$6.75M(+5.7%)
-$27.92M(+31.9%)
Mar 2017
-
-$6.39M(-23.7%)
-$21.16M(+43.2%)
Dec 2016
-$25.91M(+145.0%)
-$8.38M(+30.8%)
-$14.78M(+130.8%)
Sep 2016
-
-$6.40M
-$6.40M
Dec 2015
-$10.57M
-
-

FAQ

  • What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
  • What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?
  • What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?

What is Rhythm Pharmaceuticals, Inc. annual earnings before interest & taxes?

The current annual EBIT of RYTM is -$239.65M

What is the all time high annual EBIT for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is -$10.57M

What is Rhythm Pharmaceuticals, Inc. annual EBIT year-on-year change?

Over the past year, RYTM annual earnings before interest & taxes has changed by -$69.43M (-40.79%)

What is Rhythm Pharmaceuticals, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of RYTM is -$44.01M

What is the all time high quarterly EBIT for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is -$6.39M

What is Rhythm Pharmaceuticals, Inc. quarterly EBIT year-on-year change?

Over the past year, RYTM quarterly earnings before interest & taxes has changed by +$92.31M (+67.72%)

What is Rhythm Pharmaceuticals, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of RYTM is -$147.87M

What is the all time high TTM EBIT for Rhythm Pharmaceuticals, Inc.?

Rhythm Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is -$6.40M

What is Rhythm Pharmaceuticals, Inc. TTM EBIT year-on-year change?

Over the past year, RYTM TTM earnings before interest & taxes has changed by +$109.38M (+42.52%)
On this page